Pregnancy in systemic lupus erythematosus

Postgraduate Medical Journal

Volumn 77, Issue 905, 2001, Pages 157-165

  Mok, C C ^a   Wong, R W S ^b  

^a TUEN MUN HOSPITAL   (Hong Kong)

^b QUEEN MARY HOSPITAL   (Hong Kong)

Author keywords

Flare; Hormone; Pregnancy; Systemic lupus erythematosus

Indexed keywords

CYCLOPHOSPHAMIDE; IMMUNOSUPPRESSIVE AGENT;

CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG SAFETY; FEMALE; FETUS DEVELOPMENT; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPATHOGENESIS; LACTATION; MAJOR CLINICAL STUDY; META ANALYSIS; PREGNANCY COMPLICATION; RANDOMIZED CONTROLLED TRIAL; REVIEW; RISK ASSESSMENT; SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT OUTCOME; UREMIA;

ANTI-INFLAMMATORY AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIBODIES, ANTIPHOSPHOLIPID; CONTRACEPTION; DIAGNOSIS, DIFFERENTIAL; FEMALE; FETAL DEATH; HEART BLOCK; HUMANS; INFANT, NEWBORN; INFERTILITY, FEMALE; LACTATION; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; PRE-ECLAMPSIA; PRECONCEPTION CARE; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY, HIGH-RISK; PRENATAL CARE; STEROIDS;

EID: 0035092379     PISSN: 00325473     EISSN: None     Source Type: Journal    
DOI: 10.1136/pmj.77.905.157     Document Type: Review

References (92)

1. Pregnancy in systemic lupus erythematosus
2. Pregnancy in mixed connective tissue disease: Comparison with systemic lupus erythematosus
3. Systemic lupus erythematosus. VI. Analysis of the interrelationship with pregnancy
4. The endocrine system, use of exogenous estrogens, and the urogenital tract
5. The effect of cyclophosphamide pulses on fertility in patients with lupus nephritis
6. Risk factors for ovarian failure in patients with systemic lupus erythematosus receiving cyclophosphamide therapy
7. Risk of sustained amenorrhoea in patients with systemic lupus erythematosus receiving intermittent pulse cyclophosphamide therapy
8. Lupus pregnancy. Case-control prospective study demonstrating absence of lupus exacerbation during or after pregnancy
9. Prospective study of pregnancy in systemic lupus erythematosus. Results of a multidisciplinary approach
10. Lupus and pregnancy studies
11. Outcome of pregnancy in patients with systemic lupus erythematosus. A prospective study
12. Frequency of lupus flare in pregnancy in pregnancy. The Hopkins Lupus Pregnancy Center experience
13. Increased rate of lupus flare during pregnancy and the puerperium: A prospective study of 78 pregnancies
14. Assessing disease activity in SLE patients during pregnancy
15. Pregnancy and systemic lupus erythematosus
16. Effect of pregnancy in patients with lupus nephropathy
17. Lupus nephropathy and pregnancy: Report of 104 cases in 36 patients
18. Pregnancy in lupus nephritis and related disorders
19. Outcome criteria for lupus nephritis trials: A critical overview
20. The mother in systemic lupus erythematosus
21. The outcome of pregnancy in women with lupus nephritis
22. Lupus nephritis and pregnancy
23. Pregnancy in lupus nephropathy
24. Risk factors for preeclampsia in healthy nulliparous women: A prospective multicenter study
25. Underlying disorders associated with severe early-onset preeclampsia
26. Serum complement values (C3 and C4) to differentiate between systemic lupus activity and pre-eclampsia
27. Pregnancy in SLE
28. Systemic lupus erythematosus. VI. Analysis of the interrelationship with pregnancy
29. Factors associated with fetal losses in severe systemic lupus erythematosus
30. A prospective, controlled multicenter study on the obstetric risks of pregnant women with antiphospholipid antibodies
31. Association of quantitative anticardiolipin antibody levels with fetal loss and time of loss in systemic lupus erythematosus
32. Relationship of antiphospholipid antibodies to pregnancy loss in patients with systemic lupus erythematosus: A cross-sectional study
33. Antibody to cardiolipin as a predictor of fetal distress or death in pregnant patients with systemic lupus erythematosus
34. Clinical predictors of fetal outcome in systemic lupus erythematosus
35. Distribution and clinical significance of lupus anticoagulant and anticardiolipin antibody in 349 patients with systemic lupus erythematosus
36. Antiphospholipid syndrome in pregnancy. Obstetric concerns and treatment
37. Repeated fetal losses associated with antiphospholipid antibodies: A collaborative randomized trial comparing prednisone with low-dose heparin treatment
38. Comparative trial of prednisone plus aspirin versus aspirin alone in the treatment of anticardiolipin antibody-positive obstetric patients
39. Antiphospholipid antibody-associated recurrent pregnancy loss: Treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone
40. A clinical trial for the treatment of antiphospholipid antibody-associated recurrent pregnancy loss with lower dose heparin and aspirin
41. Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with antiphospholipid antibodies
42. Autoimmune-associated congenital heart block: Demographics, mortality, morbidity and recurrence rates obtained from a national neonatal lupus registry
43. Pregnancy in lupus
44. Immune-mediated congenital heart block (CHB): Identifying and counseling patients at risk for having children with CHB
45. The fetus in systemic lupus erythematosus
46. Anti-SS-A antibodies and fetal outcome in maternal systemic lupus erythematosus
47. Neonatal lupus syndromes
48. Influence of acetylsalicylic acid, an inhibitor of prostaglandin synthesis, on the duration of human gestation and labour
49. Lupus pregnancy
50. Fetal effects of regular salicylate ingestion in pregnancy
51. First-trimester drug use and congenital disorders
52. Production of congenital defects in the offspring of pregnant mice treated with cortisone
53. Cleft palate in the mouse: A teratogenic index of glucocorticoid potency
54. Systemic lupus erythematosus flares during pregnancy
55. Effects of immunosuppressive drugs during pregnancy
56. Outcome of treated pregnancies in women with antiphospholipid syndrome: An update of the Utah experience
57. Antimalarial agents and lupus
58. Hydroxychloroquine in pregnant patients with systemic lupus erythematosus
59. Antimalarial drugs in pregnancy - The North American experience
60. Hydroxychloroquine and lupus pregnancy: Review of a series of 36 cases
61. A randomized study of the effect of withdrawing hydroxychloroquine sulfate in systemic lupus erythematosus
62. Immunosuppressive drug use during pregnancy
63. National Transplantation Pregnancy Registry: Analysis of outcome/risks of 394 pregnancies in kidney transplant recipients
64. Retardation of fetal growth in patients receiving immunosuppressive therapy
65. Pregnancy outcome in women with systemic lupus erythematosus treated with immunosuppressive drugs
66. Teratogenicity and carcinogenicity in a twin exposed in utero to cyclophosphamide
67. National transplantation Pregnancy Registry - Outcomes of 154 pregnancies in cyclosporine-treated female kidney transplant recipients
68. Long-term nephrotoxicity after exposure to cyclosporin in utero
69. Excretion of salicylate in human milk
70. The transfer of drugs and other chemicals into human milk
71. Prednisone excretion in human milk
72. Prolactin and immunomodulation
73. Prolactin and gonadal hormones during pregnancy in systemic lupus erythematosus
74. Longstanding hyperprolactinemia associated with systemic lupus erythematosus: Possible hormonal stimulation of an autoimmune disease
75. Prolactin in systemic lupus erythematosus
76. No correlation between prolactin levels and clinical activity in patients with systemic lupus erythematosus
77. Hyperprolactinemia in systemic lupus erythematosus?
78. Prolactin profile in a cohort of Chinese systemic lupus erythematosus patients
79. Breast-feeding and postpartum relapse in women with rheumatoid and inflammatory arthritis
80. Systemic lupus erythematosus exacerbated by breast-feeding
81. Oral contraceptives and exacerbation of lupus erythematosus
82. Systemic lupus erythematosus exacerbated by oral contraceptives
83. Oral contraceptive-induced lupus erythematosus in a Japanese woman
84. Oral contraceptives and systemic lupus erythematosus
85. Influence of oral contraceptive therapy on activity of systemic lupus erythematosus
86. Oral contraceptives in systemic lupus erythematosus: Side effects and influence on the activity of SLE
87. Can women with systemic lupus erythematosus safely use exogenous estrogens?
88. Flares in the SELENA oral contraceptive trial
89. Contraceptive practice in women with systemic lupus erythematosus
90. Complications of oral contraceptives and antiphospholipid antibodies
91. Pregnancy in women with renal disease and moderate renal insufficiency
92. Pregnancy in women on hemodialysis and peritoneal dialysis